IFNA2 and cryohydrocytosis: A meta-analysis of 11 clinical trials conducted in Western countries and Japan showed that IFN-α–based antiviral therapy led to a significant decrease in proteinuria and stabilization of serum creatinine levels with greater improvement in protein excretion in CHC patients14.